ZALEPLON
NDC 65862-215, ZALEPLON, capsule, from Aurobindo Pharma Limited.
- Product NDC
- 65862-215
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078829
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/65862-215 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZALEPLON10 mg/1
Pharmacologic classes
Central Nervous System Depression [PE]; GABA A Agonists [MoA]; gamma-Aminobutyric Acid A Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-215-01 | 65862021501 | 100 CAPSULE in 1 BOTTLE (65862-215-01) |
| 65862-215-05 | 65862021505 | 500 CAPSULE in 1 BOTTLE (65862-215-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e092f3ca-bf44-4568-a72c-3fb2cf5b192bNADAC price for package 65862021501
GET /v1/drugs/nadac/65862021501
Use it
Look up 65862-215 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-215 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-215. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.